from [2003] [2004] [2005] [2006] . Patients with oropharyngeal SCC (OPSCC) (nϭ115) treated between 2003 -2006 had improved DFS compared to OPSCC patients treated between 1997 -2002 . Subgroup analysis revealed no difference in DFS between patients with laryngeal SCC (nϭ31) from the same date ranges. CONCLUSION: Planned neck dissections may not be necessary following treatment with CCR for all patients with advanced (N2 or N3) cervical nodal metastatic disease. Patients with OPSCC treated between 2003 and 2006 had improved DFS compared to earlier dates. Improved survival in OPSCC, in more recent years, may relate to better treatment strategies or represent increased incidence of HPV-associated cancers with associated improvement in response rates amongst tumors caused by HPV.
PTPN13 Expression Correlates with Survival in HPV؉ HNSCC
George Harris, MD (presenter); Aaron Bossler, MD, PhD OBJECTIVE: The human papillomavirus (HPV) oncogene E6 has been shown to perform multiple functions (p53 degradation, telomerase activation, etc.) that play a role in oncogenic transformation. Beyond known E6 functions, a recently defined mechanism that allows cellular invasion requires the E6 PDZ binding motif (PDZBM) to induce loss of a protein tyrosine phosphatase (PTPN13) in a PDZBM-dependent manner. However, variations in PTPN13 expression within HPVpositive and -negative tumors can be identified. Our first objective was to quantify this variation among a cohort of oropharyngeal squamous cell carcinomas (OPSCC). The second objective was to correlate survival differences within the cohort. METHOD: Retrospective review of patients in the UIHC Oncology Registry with oropharyngeal HNSCC who were diagnosed in 1995 and who had tissue samples available for analysis (Nϭ21). HPV typing and activity was done by RT-PCR and DNA was extracted from paraffin-embedded blocks, followed by sequencing and the use of genetic databases for typing. Immunohistochemistry was used to evaluate the status of PTPN13. Direct comparisons and multivariant analysis examined the correlation of HPV status, PTPN13 status, and survival over greater than 10 years. RESULTS: HPV was identified and activity was confirmed by increased p16 immunochemical staining, an accepted marker of HPV activity. Immunohistochemistry demonstrated variable expression of PTPN13 in HPV-positive tumors. Patients with HPV-positive squamous cell carcinoma and decreased PTPN13 had a significantly increased observed survival (pϭ0.016) versus HPV-positive patients with elevated or unchanged PTPN13. An average increase in survival of about 30 months was seen for those patients who had decreased expression of PTPN13 within the tumor.
CONCLUSION:
These findings suggest that patients who develop HNSCC associated with HPV without the additional genetic hit associated with abnormal PTPN13 have improved survival, possibly related to less genetic changes. Analyzing PTPN13 status in HPV-positive HNSCC may identify those patients that will have better survival or, conversely, those patients which may require additional treatment.
Race as a Social Construct in Head and Neck Cancer Outcomes
Maria Worsham, PhD, FACMG (presenter); George Divine, PhD; Rick Kittles, PhD OBJECTIVE: Racial differences in diagnosis and prognosis outcomes in head and neck squamous cancer (HNSCC) are usually based on self-reported race, which does not allow for the critical scientific investigation of biological factors. Here we used ancestry informative markers (AIMs) to estimate individual ancestry (IA) to test if West African genetic ancestry contributed to stage and survival outcomes in a primary HNSCC cohort. METHOD: 109 AIMS for West Africa and European genetic background were assayed in 358 patients with HNSCC who self-reported race as Caucasian American (CA), African American (AA), or other. Associations with stage at diagnosis (late vs early stage) and overall survival (time to death) were analyzed using logistic regression and Cox regression modeling, respectively, accounting for demographic, histopathology, and clinical risk variables, including smoking and alcohol. A subgroup analysis for diagnosis and survival was performed for self-reported AAs with West African IA of 15% or more. RESULTS: There were significant associations between stage and self-reported race [pϭ0.036] and with cancer site [pϭ0.001]. For prognosis, there were significant associations between stage, age group, and cancer site, but self-reported race was not associated with overall survival (pϭ0.384). There was no association with degree of West African ancestry and stage or survival. CONCLUSION: In this study, only self-reported race was associated with stage. Stratification within the AA group by IA showed no correlation with stage or survival, suggesting that race as a risk factor for head and neck cancer outcomes are likely due to social determinants rather than biological differences.
Racial Disparity in HPV Prevalence in SCCHN Patients
Kristen Angster, BS (presenter); Lisa Schumaker, BS; Shital Patel, MD (MBBS); Duane Sewell, MD; Kevin Cullen, MD OBJECTIVE: 1) Investigate the prevalence of HPV positive oropharyngeal cancer in black vs white patients; 2) Understand the impact this disparity has on overall survival.
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